Evolution of treatment strategies for calciphylaxis

American Journal of Nephrology

Volumn 34, Issue 5, 2011, Pages 460-467

  Ross, Edward A ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Calcific uremic arteriolopathy; Calciphylaxis; Vascular calcification

Indexed keywords

ALENDRONIC ACID; CALCIMIMETIC AGENT; CINACALCET; ETIDRONIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PAMIDRONIC ACID; PARATHYROID HORMONE; SODIUM THIOSULFATE; WARFARIN;

BONE MINERALIZATION; BONE TURNOVER; CALCIFICATION; CALCIUM HOMEOSTASIS; CLINICAL FEATURE; CYTOKINE RELEASE; DEBRIDEMENT; DEMOGRAPHY; DIALYSIS; DRUG EFFICACY; DRUG INDUCED HEADACHE; HUMAN; HYPERBARIC OXYGEN; INFLAMMATION; ISCHEMIA; KIDNEY CALCIFICATION; MACROPHAGE ACTIVATION; NAUSEA AND VOMITING; PARATHYROIDECTOMY; PRIORITY JOURNAL; REVIEW; RHINORRHEA; RISK FACTOR; SIGNAL TRANSDUCTION; SKIN TRANSPLANTATION; WOUND CARE;

CALCIPHYLAXIS; HUMANS;

EID: 80053504996     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000332221     Document Type: Review

References (29)

1. Selye H, Gentile G, Prioreschi P: Cutaneous molt induced by calciphylaxis in the rat. Science 1961; 134: 18 76-18 7 7.
2. Gipstein RM, Coburn JW, Adams DA, Lee DB, Parsa KP, Sellers A, Suki WN, Massry SG: Calciphylaxis in man. A syndrome of tissue necrosis and vascular calcification in 11 patients with chronic renal failure. Arch Intern Med 1976; 136: 1273-1280.
3. Danziger J: Vitamin K-dependent proteins, warfarin, and vascular calcification. Clin J Am Soc Nephrol 2008; 3:1504-1510.
4. Nigwekar SU, Wolf M, Sterns RH, Hix JK: Calciphylaxis from nonuremic causes: a systematic review. Clin J Am Soc Nephrol 2008; 3:1139-1143.
5. Weenig RH: Pathogenesis of calciphylaxis: Hans Selye to nuclear factor kappa-B. J Am Acad Dermatol 2008; 58: 458-471.
6. Wu SY, Zhang BH, Pan CS, Jiang HF, Pang YZ, Tang CS, Qi YF: Endothelin-1 is a potent regulator in vivo in vascular calcification and in vitro in calcification of vascular smoot h mus c le cel ls. Pept id e s 2 0 03; 24:1149-1156. (Pubitemid 37386301)
7. Sowers KM, Hayden MR: Calcific uremic ar-teriolopathy: pathophysiology, reactive oxygen species and therapeutic approaches. Oxid Med Cell Longev 2010; 3:109-121.
8. O'Neill WC, Lomashvili KA, Malluche HH, Faugere MC, Riser BL: Treatment with pyro-phosphate inhibits uremic vascular calcification. Kidney Int 2011; 79: 51 2-517.
9. Persy VP, McKee MD: Prevention of vascular calcification: is pyrophosphate therapy a solution? Kidney Int 2011; 79: 490-493.
10. Lomashvili KA, Wang X, Wallin R, O'Neill WC: Matrix gla protein metabolism in vascular smooth muscle and role in uremic vascular calcification. J Biol Chem 2011; 286: 28715-28722.
11. Rogers NM, Coates PT: Calcific uraemic ar-teriolopathy: an update. Curr Opin Nephrol Hyper tens 2008; 1 7: 629-63 4.
12. Phanish MK, Kallarackal G, Ravanan R, Lawson TM, Baboolal K: Tumoral calcinosis associated with pyrexia and systemic inflammatory response in a haemodialysis patient: successful treatment using intravenous pamidronate. Nephrol Dial Transplant 2000; 15: 16 91-16 9 3.
13. Sen U, Vacek TP, Hughes WM, Kumar M, Moshal KS, Tyagi N, Metreveli N, Hayden MR, Tyagi SC: Cardioprotective role of sodium thiosulfate on chronic heart failure by modulating endogenous H2S generation. Pharmacology 2008; 82: 201-213.
14. Guerra G, Shah RC, Ross EA: Rapid resolution of calciphylaxis with intravenous sodium thiosulfate and continuous venovenous haemofiltration using low calcium replacement fluid: case report. Nephrol Dial Transplant 2005; 20:1260-1262. (Pubitemid 40862124)
15. Brucculeri M, Cheigh J, Bauer G, Serur D: Long-term intravenous sodium thiosulfate in the treatment of a patient with calciphy-la xis. Semin Dial 2005; 1 8: 431-434. (Pubitemid 41545879)
16. Cicone JS, Petronis JB, Embert CD, Spector DA: Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis 2004; 43:1104-1108. (Pubitemid 38691507)
17. Singh R P, Derendorf H, Ross EA: Simulation-based sodium thiosulfate dosing strategies for the treatment of calciphylaxis. Clin J Am Soc Nephrol 2011; 6:1155-1159.
18. Farese S, Stauffer E, Kalicki R, Hildebrandt T, Frey BM, Frey FJ, Uehlinger DE, Pasch A: Sodium thiosulfate pharmacokinetics in he-modialysis patients and healthy volunteers. Clin J Am Soc Nephrol 2011; 6:1447-1455.
19. Raymond CB, Wazny LD: Sodium thio-sulfate, bisphosphonates, and cinacalcet for treatment of calciphylaxis. Am J Health Syst Pharm 2008; 65:1419-1429.
20. Kyritsis I, Gombou A, Griveas I, Agroyannis I, Retsa K, Ag roya nnis B: Combi nation of sodium thiosulphate, cinacalcet, and paricalci-tol in the treatment of calciphylaxis with hy-perparathyroidism. Int J Artif Organs 2008; 31: 742-744.
21. Araya CE, Fennell RS, Neiberger RE, Dharnidharka VR: Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults. Clin J Am Soc Nephrol 2006; 1:1161-1166.
22. Hana f usa T, Ya maguchi Y, Ta n i M, Umega k i N, Nishimura Y, Katayama I: Intractable wou nd s c au sed by ca lci f ic uremic ar ter iolop-athy treated with bisphosphonates. J Am Acad Dermatol 2007; 57: 10 21-10 2 5.
23. Shiraishi N, Kitamura K, Miyoshi T, Adachi M, Kohda Y, Nonoguchi H, Misumi S, Maekawa Y, Murayama T, Tomita M, Tomita K: Successful treatment of a patient with severe calcific uremic arteriolopathy (calci-phylaxis) by etidronate disodium. Am J Kidney Dis 2006; 48:151-154.
24. Monney P, Nguyen QV, Perroud H, Descombes E: Rapid improvement of calci-phylaxis after intravenous pamidronate therapy in a patient with chronic renal failure. Nephrol Dial Transplant 2004; 19: 2130-2132. (Pubitemid 39139649)
25. da Costa JB, da Costa AG, Gomes MM: Pamidronate as a treatment option in calci-phylaxis. J Eur Acad Dermatol Venereol 2008; 22:1128-1130.
26. Don BR, Chin AI: A strategy for the treatment of calcific uremic arteriolopathy (calci-phylaxis) employing a combination of therapies. Clin Nephrol 2003; 59: 463-470 (Pubitemid 36722329)
27. The UK calciphylaxis registry. http://www. renal.org/academic/ UKCalciphylaxisRegis-try.aspx (accessed August 2, 2011).
28. German Calciphylaxis Registry. http://www. klinikumcoburg.de/index.php? id=103&L=1 (accessed August 2, 2011).
29. Calciphylaxis registry. KU Medical Center, The University of Kansas. http://www2. kumc.edu/calciphylaxisregistry/(accessed August 2, 2011).